😱Shocking Move from US Company: Joined $HYPE , Billions in Preparation!🔥🇺🇸

US-based biotechnology company Sonnet BioTherapeutics is making headlines not only with its health technologies but also with its crypto strategies. The Nasdaq-listed company has made a splash in the crypto markets with a major merger.

💥 HYPE at the Heart of the Transformation!

Sonnet BioTherapeutics will merge with Rorschach I LLC, backed by Atlas Merchant Capital, and change its name to Hyperliquid Strategies, Inc. At the heart of the new structure is HYPE, the cryptocurrency token that has been making headlines lately.

Following the merger, the company will hold:

12.6 million #hype tokens

$305 million in cash

The total valuation of the resulting company following this massive merger will be approximately $888 million.

The new company will continue to trade on Nasdaq under a new ticker symbol and will implement a crypto treasury management model strategically designed around the $HYPE token.